Indeed, the Gly4( S,S )-ACPC derivative of exendin-4 proved to be an even more potent antagonist than exendin-(9-39), which is currently in clinical trials for the treatment of post-bariatric hypoglycemia (Fig
Cancer Med
4 Department of Neurology, University Hospitals Birmingham National Health Service (NHS) Foundation Trust, Queen Elizabeth Hospital, Birmingham, United Kingdom
Plant-based compounds like berberine and curcumin have shown early promise in supporting blood sugar control and GLP-1 pathways
He then introduces semaglutide, a recently-approved drug which has been shown to result in 15% weight loss over 2 years
GLP-1 use was associated with changes in nicotine cravings, with 24.4% of participants reporting a reduction in cravings